Author: Devi Dayal; Saniya Gupta
Title: Connecting BCG Vaccination and COVID-19: Additional Data Document date: 2020_4_8
ID: by4aefjc_11
Snippet: The protection offered by BCG vaccine to SARS-CoV-2 has been attributed to its nonspecific effects (NSEs) (11). The range of NSEs include a reduction in the incidence of respiratory tract infections in children, antiviral effects and reduced viremia in experimental animals (11). For several viruses such as respiratory syncytial virus, yellow fever, herpes . CC-BY 4.0 International license It is made available under a author/funder, who has grante.....
Document: The protection offered by BCG vaccine to SARS-CoV-2 has been attributed to its nonspecific effects (NSEs) (11). The range of NSEs include a reduction in the incidence of respiratory tract infections in children, antiviral effects and reduced viremia in experimental animals (11). For several viruses such as respiratory syncytial virus, yellow fever, herpes . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Search related documents:
Co phrase search for related documents- antiviral effect and international license: 1, 2, 3, 4
- antiviral effect and nonspecific effect: 1
- antiviral effect and respiratory syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antiviral effect and syncytial virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- BCG vaccine and cc international license: 1, 2, 3
- BCG vaccine and experimental animal: 1, 2
- BCG vaccine and international license: 1, 2, 3
- BCG vaccine and nonspecific effect: 1
- BCG vaccine and respiratory syncytial virus: 1, 2
- BCG vaccine and SARS BCG vaccine offer: 1, 2
- BCG vaccine and SARS BCG vaccine offer protection: 1, 2
- BCG vaccine and syncytial virus: 1, 2
- BCG vaccine offer and SARS BCG vaccine offer: 1, 2
- BCG vaccine offer and SARS BCG vaccine offer protection: 1, 2
- cc international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cc international license and respiratory syncytial virus: 1, 2, 3, 4, 5, 6
- cc international license and syncytial virus: 1, 2, 3, 4, 5, 6
- child tract infection and respiratory child tract infection: 1, 2, 3, 4, 5, 6, 7, 8
- child tract infection and respiratory child tract infection incidence: 1
Co phrase search for related documents, hyperlinks ordered by date